July 27, 2020

Logos Biosystems’ QUANTOM Tx™ helps microbiologist on mission to develop new therapies against Staphylococcus aureus

In an exclusive interview with leading independent science publisher SelectScience®, Head of Molecular Bacteriology at University Hospital Heidelberg, Dr. Dennis Nurjadi discusses his lab’s work on Staphylococcus aureus.

Nurjadi explains the importance of understanding its key mechanisms in order to develop new therapies to decolonize high-risk patients and prevent S. aureus infections.

Specifically, the team is researching the interaction between S. aureus and keratinocytes and looking at the immunological response, how skin cells/keratinocytes sense and differentiate between pathogen and commensal organisms.

“We would like to understand the mechanism behind S. aureus colonization better and why commensal organisms on the skin are tolerated by the skin’s immune defense mechanisms,” says Nurjadi. “A better understanding of the host-pathogen interplay may contribute to develop novel strategies for the decolonization of high-risk patients and prevent S. aureus infections.”

Nurjadi goes on to discuss the challenges in his research, in particular the accurate quantification of bacteria, and how the QUANTOM Tx™ Microbial Cell Counter has made all the difference.

Find out more about Nurjadi’s interesting work and the part played by Logos Biosystems’ QUANTOM Tx™ in the full article here>>

The QUANTOM Tx™ Microbial Cell Counter